26 September 2023 in Clinical Oral Implants Research
Purpose: The aim of this review was to evaluate the survival rates of restorations utilizing titanium base abutments (TBA) for restoring single‐unit implant prostheses.Materials and Methods: This review was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) guidelines. The focus question was: In patients who require the restoration of a single dental implant utilizing a titanium base abutment, what are the determining factors and outcomes relating to implant prosthesis prognosis and survival? A comprehensive search of databases (PubMed, EMBASE, and Cochrane Library) was conducted on 16 April 2023 and updated on 5 May 2023. Randomized clinical trials (RCT), retrospective studies and prospective studies, reporting on the use of TBA for single implant prostheses, were reviewed. A Cochrane collaboration risk of bias assessment analysis was performed for randomized clinical studies, and the Newcastle–Ottawa Scale tool was applied for non‐randomized studies. A meta‐analysis was performed on clinical trials reporting on survival rates of both TBA and other abutments. Other clinical studies, reporting on TBA only, were included for descriptive statistics.Results: The search provided 1159 titles after duplicates were removed. Six RCTs were included to perform a meta‐analysis and compare the survival of the TBA to other abutments [OR 0.74; 95% CI: 0.21–2.63, heterogeneity; I2 0%; p = .99]. Twenty‐three prospective and retrospective studies fulfilled the criteria and were included in the meta‐analysis after 12 months of function. A total of 857 single implant‐supported prostheses fabricated with a TBA were included. TBA abutments have an estimate 98.6% survival rate after 1 year in function (95% CI: 97.9%–99.4%). The mean follow‐up period was 31.2 ± 16.9 months.Conclusions: Single implant prosthesis restored with titanium base abutments showed favourable short‐term survival rates.